Givinostat
Givinostat
Givinostat (pronounced: giv-in-o-stat) is a histone deacetylase inhibitor that is currently under investigation for its potential therapeutic applications in various medical conditions.
Etymology
The name "Givinostat" is derived from the name of the company that first developed it, Givaudan, and the term "stat", which is commonly used in the naming of drugs that inhibit or "stop" a particular biological process.
Medical Uses
Givinostat has been studied for its potential use in the treatment of various medical conditions, including polycythemia vera, systemic-onset juvenile idiopathic arthritis, and Duchenne muscular dystrophy. It works by inhibiting the activity of histone deacetylases, a group of enzymes that play a key role in the regulation of gene expression.
Related Terms
- Histone deacetylase inhibitor: A class of drugs that inhibit the activity of histone deacetylases, enzymes that play a key role in the regulation of gene expression.
- Polycythemia vera: A slow-growing blood cancer in which your bone marrow makes too many red blood cells.
- Systemic-onset juvenile idiopathic arthritis: A subtype of juvenile idiopathic arthritis that begins with symptoms such as fever, rash, and arthritis.
- Duchenne muscular dystrophy: A genetic disorder characterized by progressive muscle degeneration and weakness.
See Also
External links
- Medical encyclopedia article on Givinostat
- Wikipedia's article - Givinostat
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski